Public Profile

Guardant Health

Guardant Health, Inc., a leading precision oncology company, is headquartered in the United States, with significant operations across North America and Europe. Founded in 2012, the company has rapidly established itself in the biotechnology industry, focusing on non-invasive cancer detection and monitoring through advanced genomic testing. Guardant Health is renowned for its flagship product, the Guardant360® test, which provides comprehensive genomic profiling of solid tumours using a simple blood draw. This innovative approach allows for personalised treatment strategies, setting the company apart in the competitive landscape of cancer diagnostics. With a strong market position, Guardant Health has achieved notable milestones, including partnerships with major pharmaceutical companies and contributions to pivotal clinical trials. Its commitment to transforming cancer care through cutting-edge technology continues to drive its success in the oncology sector.

DitchCarbon Score

How does Guardant Health's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

32

Industry Average

Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

25

Industry Benchmark

Guardant Health's score of 32 is higher than 90% of the industry. This can give you a sense of how well the company is doing compared to its peers.

90%

Let us know if this data was useful to you

Guardant Health's reported carbon emissions

In 2023, Guardant Health reported total carbon emissions of approximately 4,222,000 kg CO2e, comprising 1,659,000 kg CO2e from Scope 1 and 2,563,000 kg CO2e from Scope 2 emissions. The company has set ambitious near-term targets to significantly reduce its carbon footprint, aiming for near-zero emissions in both Scope 1 and Scope 2 by 2025. Additionally, Guardant Health is committed to a 30% reduction in Scope 1 and Scope 2 emissions from a 2023 baseline by 2030. These initiatives reflect the company's dedication to addressing climate change within the pharmaceuticals, biotechnology, and life sciences sector, aligning with industry standards for sustainability and environmental responsibility.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2023
Scope 1
1,659,000
Scope 2
2,563,000
Scope 3
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Guardant Health's primary industry is Research and development services (73), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Guardant Health is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Guardant Health is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Myriad Genetics, Inc.

US
Health and social work services (85)
Updated 20 days ago

Nanostring Technologies

US
Health and social work services (85)
Updated 20 days ago

OPKO Health, Inc.

US
Other business services (74)
Updated 20 days ago

GeneDx Holdings Corp.

US
Other business services (74)
Updated 20 days ago

Neogenomics

US
Other business services (74)
Updated 20 days ago

Personalis

US
Health and social work services (85)
Updated 20 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers